Pediatric Fatty Liver disease is a growing problem in the United States and is expected to be the leading cause of Liver Transplantation in Adults in 20 years.…

Non-Alcoholic Fatty Liver Disease (NAFLD)

~Estimated

~$10 – $6,250

University Hospitals Cleveland Medical CenterNCT06477146

Observational

Development and Diagnostic Evaluation of a Novel Quantifiable Ultrasound Based Multi-parametric Biomarker for Hepatic Steatosis in Patients With Suspected MASLD ( LYNX )

The research study is considering a non-invasive way to measure the percentage of fat in the liver using ultrasound. This could help detect early signs of a ve…

MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease

~Estimated

~$10 – $7,500

ContextVision ABNCT07270601

← PreviousPage 3 of 3Next →